When does the vedolizumab (Vedolizumab tab alvotech) patent expire?
I can’t determine a specific patent expiry date for “vedolizumab tab alvotech” from the information provided here. The expiry date depends on which exact Alvotech/competitor product is meant (the specific jurisdiction and whether the question is about primary patents, pediatric exclusivity, patent term adjustments, or biologics exclusivity).
Which patent/exclusivity type are you looking for (and why the date can differ)?
For medicines like vedolizumab (a biologic), “expiry” can refer to different legal protections that end on different dates, such as:
- Patent term (the last day a listed patent is enforceable).
- Biologics exclusivity (a separate statutory exclusivity period).
- Supplemental protections (for example, extensions tied to regulatory or pediatric timing).
- Country-specific differences (US vs EU vs UK vs others).
How to get the exact expiry date quickly (what to check)
To pin down the correct expiry date, you typically need:
- The country (e.g., US, EU, UK).
- The specific reference product (vedolizumab originator name).
- The list of patents tied to that product in that jurisdiction.
- The relevant exclusivity regime.
Where DrugPatentWatch can help
DrugPatentWatch compiles patent and exclusivity information that can be used to identify the last relevant protection for a given biologic and market. You can check the exact entry for vedolizumab there: DrugPatentWatch.
If you share 2 details, I can narrow it to a single expiry date
Reply with:
1) The country/market (US, EU, UK, etc.), and
2) The exact product name you mean by “Vedolizumab tab alvotech” (the approved/marketed Alvotech product name or application reference, if you have it).
With that, I can give a specific expiry date tied to the right patents/exclusivity.
Sources
- DrugPatentWatch